Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Moncef Slaoui
Biotech
Centessa Pharma, wasting no time, tees up $100M IPO
Two months after launching with $250 million and a clutch of clinical and preclincal prospects, Centessa wants to raise up to $100 million in its IPO.
Amirah Al Idrus
Apr 21, 2021 6:16pm
GSK cuts Slaoui ties over harassment claims—Chutes & Ladders
Mar 26, 2021 9:30am
Centessa adds ex-FDA commish Califf, biotech bigwigs to board
Mar 11, 2021 12:18pm
Merck must do a new trial for faltering $425M COVID-19 drug
Mar 3, 2021 7:55am
Life after Warp: Slaoui not slowing down
Feb 16, 2021 6:30am
AZ sues exec Luke Miels after his defection to GSK
May 16, 2017 9:52am